What is the in vivo mechanism of action of levosimendan? [1]

Journal of Cardiac Failure

Volumn 11, Issue 6, 2005, Pages 482-

  MacGowan, Guy A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP; LEVOSIMENDAN; PHOSPHODIESTERASE; TROPONIN C;

CONGESTIVE HEART FAILURE; DRUG ACTIVITY; DRUG BINDING; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ACTINS; CALCIUM; CARDIOTONIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; HYDRAZONES; MYOSINS; PHOSPHODIESTERASE INHIBITORS; PYRIDAZINES; TROPONIN C;

EID: 33644601367     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.07.001     Document Type: Letter

References (7)

1. M. Endoh Mechanism of action of novel cardiotonic agents J Cardiovasc Pharm 40 2002 323 338
2. R.J. Hajjar, U. Schmidt, P. Helm, and J.K. Gwathmey Ca++ sensitizers impair cardiac relaxation in failing human myocardium J Pharmacol Exp Ther 280 1997 247 254
3. H. Haikala, J. Kaivola, E. Nissinen, P. Wall, J. Levijoki, and I.B. Linden Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan J Mol Cell Cardiol 27 1995 1859 1866
4. G. Hasenfuss, B. Pieske, M. Castell, B. Kretschmann, L.S. Maier, and H. Just Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium Circulation 98 1998 2141 2147
5. M. Packer, J.R. Carver, R.J. Rodeheffer, R.J. Ivanhoe, R. DiBianco, and S.M. Zeldis Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group N Engl J Med 325 1991 1468 1475
6. 2+ sensitivity of force is enhanced in failing human hearts Cardiovasc Res 57 2003 505 514
7. T.C.C. Hu, R.G. Pautler, G.A. MacGowan, and A.P. Koretsky Non-invasive determination of altered myocardial intracellular calcium in the mouse heart with manganese enhanced MRI Magn Reson Med 46 2001 884 890